The pharmaceutical company has experienced sales growth over the past five years.On November 17, 2025, financial services firm Westshore Wealth, LLC disclosed a new position in Amneal Pharmaceuticals (AMRX +0.00%), acquiring 1,381,910 shares valued at approximately $13.83 million.Westshore initiated a stake in Amneal in the third quarter, buying 1,381,910 shares.The transaction accounted for 4.73% of Westshore Wealth's 13F reportable assets under management.Post-trade, Westshore's total stake in Amneal was ...

Core Insights - Investors are enthusiastic about the company's weight loss treatments but may be neglecting the promising pipeline of new therapies [1] Company Performance - Eli Lilly's shares experienced a significant increase over the last month as investor confidence in its product pipeline grew [1]